Search Results

There are 3561 results for: content related to: Proceedings of the International Symposium on Prostate, Androgens and Men's Sexual Health, Berlin, G ermany, J une 21–23, 2013

  1. Proceedings of the 20th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Miami Beach, USA, November 20–23, 2014

    The Journal of Sexual Medicine

    Volume 12, Issue S2, May 2015, Pages: 101–183,

    Version of Record online : 9 APR 2015, DOI: 10.1111/jsm.12808

  2. You have full text access to this OnlineOpen article
    Continuation and effectiveness of tadalafil once daily during a 6-month observational study in erectile dysfunction: the EDATE study

    International Journal of Clinical Practice

    Volume 68, Issue 9, September 2014, Pages: 1087–1099, J. Buvat, D. Hatzichristou, F. G. Boess, H. Büttner, N. Gehchan, C. Henneges and H. Porst

    Version of Record online : 14 AUG 2014, DOI: 10.1111/ijcp.12449

  3. Proceedings of the 19th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, New Orleans, USA, November 21–24 2013

    The Journal of Sexual Medicine

    Volume 11, Issue S3, April 2014, Pages: 138–204,

    Version of Record online : 14 APR 2014, DOI: 10.1111/jsm.12528

  4. Effect of Tadalafil on Cytochrome P450 3A4–mediated Clearance: Studies in Vitro and in Vivo

    Clinical Pharmacology & Therapeutics

    Volume 77, Issue 1, January 2005, Pages: 63–75, Barbara J. Ring, Beverley E. Patterson, Malcolm I. Mitchell, Mark Vandenbranden, Jennifer Gillespie, Alun W. Bedding, Hayley Jewell, Christopher D. Payne, S. Thomas Forgue, James Eckstein, Steven A. Wrighton and Diane L. Phillips

    Version of Record online : 16 JAN 2005, DOI: 10.1016/j.clpt.2004.09.006

  5. Tadalafil inclusion in microporous silica as effective dissolution enhancer: Optimization of loading procedure and molecular state characterization

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 5, May 2011, Pages: 1805–1818, Mohammed M. Mehanna, Adel M. Motawaa and Magda W. Samaha

    Version of Record online : 22 DEC 2010, DOI: 10.1002/jps.22420

  6. You have free access to this content
    Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized placebo- and tamsulosin-controlled 12-week study in Asian men

    International Journal of Urology

    Volume 20, Issue 2, February 2013, Pages: 193–201, Osamu Yokoyama, Masaki Yoshida, Sae Chul Kim, Chii-Jye Wang, Takeshi Imaoka, Yoji Morisaki and Lars Viktrup

    Version of Record online : 7 SEP 2012, DOI: 10.1111/j.1442-2042.2012.03130.x

  7. Tadalafil Enhances the Inhibitory Effects of Tamsulosin on Neurogenic Contractions of Human Prostate and Bladder Neck

    The Journal of Sexual Medicine

    Volume 9, Issue 9, September 2012, Pages: 2293–2306, Javier Angulo, Pedro Cuevas, Argentina Fernández, José M. La Fuente, Antonio Allona, Ignacio Moncada and Iñigo Sáenz de Tejada

    Version of Record online : 3 JUL 2012, DOI: 10.1111/j.1743-6109.2012.02821.x

  8. Safety, Efficacy, and Pharmacokinetic Overview of Low-Dose Daily Administration of Tadalafil

    The Journal of Sexual Medicine

    Volume 6, Issue 7, July 2009, Pages: 2039–2048, Rebecca Wrishko, Sebastian Sorsaburu, David Wong, Andrew Strawbridge and James McGill

    Version of Record online : 28 APR 2009, DOI: 10.1111/j.1743-6109.2009.01301.x

  9. A Randomized Open-Label Trial with a Crossover Comparison of Sexual Self-Confidence and Other Treatment Outcomes Following Tadalafil Once a Day Vs. Tadalafil or Sildenafil On-Demand in Men with Erectile Dysfunction

    The Journal of Sexual Medicine

    Volume 9, Issue 5, May 2012, Pages: 1418–1429, Eusebio Rubio-Aurioles, Hartmut Porst, Edward D. Kim, Francesco Montorsi, Geoff Hackett, Antonio Martin Morales, Bronwyn Stuckey, Hartwig Būttner, Teena M. West, Ngan N. Huynh, Enrique Lenero, Patrick Burns and Vladimir Kopernicky

    Version of Record online : 16 MAR 2012, DOI: 10.1111/j.1743-6109.2012.02667.x

  10. Proceedings of the 16th World Meeting on Sexual Medicine, São Paulo, Brazil, October 8–12, 2014

    The Journal of Sexual Medicine

    Volume 12, Issue S1, January 2015, Pages: 1–96,

    Version of Record online : 22 JAN 2015, DOI: 10.1111/jsm.12826

  11. The Clinical Pharmacokinetics of Phosphodiesterase-5 Inhibitors for Erectile Dysfunction

    The Journal of Clinical Pharmacology

    Volume 45, Issue 9, September 2005, Pages: 987–1003, Dr Manish Gupta, Dr Andreas Kovar and Dr Bernd Meibohm

    Version of Record online : 19 MAR 2013, DOI: 10.1177/0091270005276847

  12. ORIGINAL RESEARCH—PHARMACOTHERAPY FOR ED: Efficacy and Safety of Daily Tadalafil in Men with Erectile Dysfunction Previously Unresponsive to On-demand Tadalafil

    The Journal of Sexual Medicine

    Volume 1, Issue 3, November 2004, Pages: 292–300, Chris McMahon

    Version of Record online : 13 OCT 2004, DOI: 10.1111/j.1743-6109.04042.x

  13. Hemodynamic Interaction Between a Daily Dosed Phosphodiesterase 5 Inhibitor, Tadalafil, and the α-Adrenergic Blockers, Doxazosin and Tamsulosin, in Middle-Aged Healthy Male Subjects

    The Journal of Clinical Pharmacology

    Volume 47, Issue 10, October 2007, Pages: 1303–1310, Dr Michel Guillaume, Dr Finnuala Lonsdale, Ms Christelle Darstein, Dr Maria C. Jimenez and Dr Malcolm I. Mitchell

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007306559

  14. Tadalafil – a therapeutic option in the management of BPH-LUTS

    International Journal of Clinical Practice

    Volume 68, Issue 1, January 2014, Pages: 94–103, C. C. Carson, M. Rosenberg, J. Kissel and D. G. Wong

    Version of Record online : 17 DEC 2013, DOI: 10.1111/ijcp.12305

  15. Comparison of Efficacy, Safety, and Tolerability of On-Demand Tadalafil and Daily Dosed Tadalafil for the Treatment of Erectile Dysfunction

    The Journal of Sexual Medicine

    Volume 2, Issue 3, May 2005, Pages: 415–427, Chris McMahon

    Version of Record online : 11 APR 2005, DOI: 10.1111/j.1743-6109.2005.20360.x

  16. You have free access to this content
    The Treatment of Erectile Dysfunction study: focus on treatment satisfaction of patients and partners

    BJU International

    Volume 99, Issue 2, February 2007, Pages: 376–382, Gerald Brock, John Chan, 1 Serge Carrier, 2 Melanie Chan, 1 Luis Salgado, 3 Alexander H. Klein, 4 Clement Lang, 5 Richard Horner, 6 Stephen Gutkin and 7 Ruth Dickson 1

    Version of Record online : 28 NOV 2006, DOI: 10.1111/j.1464-410X.2006.06586.x

  17. Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Japanese Men with Benign Prostatic Hyperplasia: Results from a 12-week Placebo-controlled Dose-finding Study with a 42-week Open-label Extension

    LUTS: Lower Urinary Tract Symptoms

    Volume 4, Issue 3, September 2012, Pages: 110–119, Masayuki TAKEDA, Osamu NISHIZAWA, Takeshi IMAOKA, Yoji MORISAKI and Lars VIKTRUP

    Version of Record online : 1 MAR 2012, DOI: 10.1111/j.1757-5672.2012.00144.x

  18. Efficacy and Safety of Oral Tadalafil in the Treatment of Men in Canada with Erectile Dysfunction: A Randomized, Double-Blind, Parallel, Placebo-Controlled Clinical Trial

    The Journal of Sexual Medicine

    Volume 2, Issue 5, September 2005, Pages: 685–698, Serge Carrier, Gerald B. Brock, Peter J. Pommerville, Janey Shin, Greg Anglin, Steven Whitaker and Charles M. Beasley Jr

    Version of Record online : 6 JUL 2005, DOI: 10.1111/j.1743-6109.2005.00097.x

  19. You have free access to this content
    Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: results from the Canadian ‘Treatment of Erectile Dysfunction’ observational study

    BJU International

    Volume 98, Issue 3, September 2006, Pages: 623–629, JAY LEE, PETER POMMERVILLE, GERALD BROCK, ROBERT GAGNON, PRAVINSAGAR MEHTA, MICHOKE KRISDAPHONGS, MELANIE CHAN, JOHN CHAN and RUTH DICKSON

    Version of Record online : 2 AUG 2006, DOI: 10.1111/j.1464-410X.2006.06384.x

  20. No clinically relevant pharmacokinetic and safety interactions of ambrisentan in combination with tadalafil in healthy volunteers

    Journal of Pharmaceutical Sciences

    Volume 98, Issue 12, December 2009, Pages: 4962–4974, Rebecca Spence, Arun Mandagere, Brooke Harrison, Christopher Dufton and Ramesh Boinpally

    Version of Record online : 19 MAY 2009, DOI: 10.1002/jps.21789